Table of Content

1 Genetically Engineered Vaccines Market Overview
1.1 Genetically Engineered Vaccines Product Overview
1.2 Genetically Engineered Vaccines Market Segment by Type
1.2.1 Genetic Recombinant Vaccine
1.2.2 Recombinant Subunit Vaccines
1.2.3 Genetic Vaccine
1.3 Global Genetically Engineered Vaccines Market Size by Type
1.3.1 Global Genetically Engineered Vaccines Market Size Overview by Type (2024-2034)
1.3.2 Global Genetically Engineered Vaccines Historic Market Size Review by Type (2024-2024)
1.3.3 Global Genetically Engineered Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Genetically Engineered Vaccines Sales Breakdown by Type (2024-2024)
1.4.2 Europe Genetically Engineered Vaccines Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Genetically Engineered Vaccines Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Genetically Engineered Vaccines Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Genetically Engineered Vaccines Sales Breakdown by Type (2024-2024)
2 Global Genetically Engineered Vaccines Market Competition by Company
2.1 Global Top Players by Genetically Engineered Vaccines Sales (2024-2024)
2.2 Global Top Players by Genetically Engineered Vaccines Revenue (2024-2024)
2.3 Global Top Players by Genetically Engineered Vaccines Price (2024-2024)
2.4 Global Top Manufacturers Genetically Engineered Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Genetically Engineered Vaccines Market Competitive Situation and Trends
2.5.1 Genetically Engineered Vaccines Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Genetically Engineered Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genetically Engineered Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Genetically Engineered Vaccines Market
2.8 Key Manufacturers Genetically Engineered Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Genetically Engineered Vaccines Status and Outlook by Region
3.1 Global Genetically Engineered Vaccines Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Genetically Engineered Vaccines Historic Market Size by Region
3.2.1 Global Genetically Engineered Vaccines Sales in Volume by Region (2024-2024)
3.2.2 Global Genetically Engineered Vaccines Sales in Value by Region (2024-2024)
3.2.3 Global Genetically Engineered Vaccines Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Genetically Engineered Vaccines Forecasted Market Size by Region
3.3.1 Global Genetically Engineered Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Genetically Engineered Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Genetically Engineered Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Genetically Engineered Vaccines by Application
4.1 Genetically Engineered Vaccines Market Segment by Application
4.1.1 Veterinary Use
4.1.2 Human Use
4.2 Global Genetically Engineered Vaccines Market Size by Application
4.2.1 Global Genetically Engineered Vaccines Market Size Overview by Application (2024-2034)
4.2.2 Global Genetically Engineered Vaccines Historic Market Size Review by Application (2024-2024)
4.2.3 Global Genetically Engineered Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Genetically Engineered Vaccines Sales Breakdown by Application (2024-2024)
4.3.2 Europe Genetically Engineered Vaccines Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Genetically Engineered Vaccines Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Genetically Engineered Vaccines Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Genetically Engineered Vaccines Sales Breakdown by Application (2024-2024)
5 North America Genetically Engineered Vaccines by Country
5.1 North America Genetically Engineered Vaccines Historic Market Size by Country
5.1.1 North America Genetically Engineered Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Genetically Engineered Vaccines Sales in Volume by Country (2024-2024)
5.1.3 North America Genetically Engineered Vaccines Sales in Value by Country (2024-2024)
5.2 North America Genetically Engineered Vaccines Forecasted Market Size by Country
5.2.1 North America Genetically Engineered Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Genetically Engineered Vaccines Sales in Value by Country (2024-2034)
6 Europe Genetically Engineered Vaccines by Country
6.1 Europe Genetically Engineered Vaccines Historic Market Size by Country
6.1.1 Europe Genetically Engineered Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Genetically Engineered Vaccines Sales in Volume by Country (2024-2024)
6.1.3 Europe Genetically Engineered Vaccines Sales in Value by Country (2024-2024)
6.2 Europe Genetically Engineered Vaccines Forecasted Market Size by Country
6.2.1 Europe Genetically Engineered Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Genetically Engineered Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Genetically Engineered Vaccines by Region
7.1 Asia-Pacific Genetically Engineered Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Genetically Engineered Vaccines Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Genetically Engineered Vaccines Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Genetically Engineered Vaccines Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Genetically Engineered Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Genetically Engineered Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Genetically Engineered Vaccines Sales in Value by Region (2024-2034)
8 Latin America Genetically Engineered Vaccines by Country
8.1 Latin America Genetically Engineered Vaccines Historic Market Size by Country
8.1.1 Latin America Genetically Engineered Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Genetically Engineered Vaccines Sales in Volume by Country (2024-2024)
8.1.3 Latin America Genetically Engineered Vaccines Sales in Value by Country (2024-2024)
8.2 Latin America Genetically Engineered Vaccines Forecasted Market Size by Country
8.2.1 Latin America Genetically Engineered Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Genetically Engineered Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Genetically Engineered Vaccines by Country
9.1 Middle East and Africa Genetically Engineered Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Genetically Engineered Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Genetically Engineered Vaccines Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Genetically Engineered Vaccines Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Genetically Engineered Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Genetically Engineered Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Genetically Engineered Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Pfizer Genetically Engineered Vaccines Products Offered
10.1.5 Pfizer Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Merck Genetically Engineered Vaccines Products Offered
10.2.5 Merck Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.3.4 GSK Genetically Engineered Vaccines Products Offered
10.3.5 GSK Recent Development
10.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
10.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Information
10.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Introduction and Business Overview
10.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Products Offered
10.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Development
10.5 Walvax Biotechnology Co., Ltd.
10.5.1 Walvax Biotechnology Co., Ltd. Company Information
10.5.2 Walvax Biotechnology Co., Ltd. Introduction and Business Overview
10.5.3 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Products Offered
10.5.5 Walvax Biotechnology Co., Ltd. Recent Development
10.6 Bharat Biotech
10.6.1 Bharat Biotech Company Information
10.6.2 Bharat Biotech Introduction and Business Overview
10.6.3 Bharat Biotech Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Bharat Biotech Genetically Engineered Vaccines Products Offered
10.6.5 Bharat Biotech Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Sanofi Genetically Engineered Vaccines Products Offered
10.7.5 Sanofi Recent Development
10.8 Zoties
10.8.1 Zoties Company Information
10.8.2 Zoties Introduction and Business Overview
10.8.3 Zoties Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Zoties Genetically Engineered Vaccines Products Offered
10.8.5 Zoties Recent Development
10.9 Elanco
10.9.1 Elanco Company Information
10.9.2 Elanco Introduction and Business Overview
10.9.3 Elanco Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Elanco Genetically Engineered Vaccines Products Offered
10.9.5 Elanco Recent Development
10.10 Boehringer Ingelheim
10.10.1 Boehringer Ingelheim Company Information
10.10.2 Boehringer Ingelheim Introduction and Business Overview
10.10.3 Boehringer Ingelheim Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Boehringer Ingelheim Genetically Engineered Vaccines Products Offered
10.10.5 Boehringer Ingelheim Recent Development
10.11 Indian Immunologicals
10.11.1 Indian Immunologicals Company Information
10.11.2 Indian Immunologicals Introduction and Business Overview
10.11.3 Indian Immunologicals Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Indian Immunologicals Genetically Engineered Vaccines Products Offered
10.11.5 Indian Immunologicals Recent Development
10.12 China Animal Husbandry Industry Co.,Ltd.
10.12.1 China Animal Husbandry Industry Co.,Ltd. Company Information
10.12.2 China Animal Husbandry Industry Co.,Ltd. Introduction and Business Overview
10.12.3 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.12.4 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Products Offered
10.12.5 China Animal Husbandry Industry Co.,Ltd. Recent Development
10.13 Yebio Bioengineering Co., Ltd Of Qingdao
10.13.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
10.13.2 Yebio Bioengineering Co., Ltd Of Qingdao Introduction and Business Overview
10.13.3 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Products Offered
10.13.5 Yebio Bioengineering Co., Ltd Of Qingdao Recent Development
10.14 Jinyu Bio-technology Co.,ltd.
10.14.1 Jinyu Bio-technology Co.,ltd. Company Information
10.14.2 Jinyu Bio-technology Co.,ltd. Introduction and Business Overview
10.14.3 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Products Offered
10.14.5 Jinyu Bio-technology Co.,ltd. Recent Development
10.15 HVRI
10.15.1 HVRI Company Information
10.15.2 HVRI Introduction and Business Overview
10.15.3 HVRI Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.15.4 HVRI Genetically Engineered Vaccines Products Offered
10.15.5 HVRI Recent Development
10.16 Ringpu Biology
10.16.1 Ringpu Biology Company Information
10.16.2 Ringpu Biology Introduction and Business Overview
10.16.3 Ringpu Biology Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Ringpu Biology Genetically Engineered Vaccines Products Offered
10.16.5 Ringpu Biology Recent Development
10.17 Kyoto Biken Laboratories
10.17.1 Kyoto Biken Laboratories Company Information
10.17.2 Kyoto Biken Laboratories Introduction and Business Overview
10.17.3 Kyoto Biken Laboratories Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Kyoto Biken Laboratories Genetically Engineered Vaccines Products Offered
10.17.5 Kyoto Biken Laboratories Recent Development
10.18 FATRO
10.18.1 FATRO Company Information
10.18.2 FATRO Introduction and Business Overview
10.18.3 FATRO Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.18.4 FATRO Genetically Engineered Vaccines Products Offered
10.18.5 FATRO Recent Development
10.19 Ceva Santé Animale
10.19.1 Ceva Santé Animale Company Information
10.19.2 Ceva Santé Animale Introduction and Business Overview
10.19.3 Ceva Santé Animale Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Ceva Santé Animale Genetically Engineered Vaccines Products Offered
10.19.5 Ceva Santé Animale Recent Development
10.20 Pulike Biological Engineering,Inc.
10.20.1 Pulike Biological Engineering,Inc. Company Information
10.20.2 Pulike Biological Engineering,Inc. Introduction and Business Overview
10.20.3 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.20.4 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Products Offered
10.20.5 Pulike Biological Engineering,Inc. Recent Development
10.21 Wuhan Hvsen Biotechnology CO.,LTD
10.21.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
10.21.2 Wuhan Hvsen Biotechnology CO.,LTD Introduction and Business Overview
10.21.3 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.21.4 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Products Offered
10.21.5 Wuhan Hvsen Biotechnology CO.,LTD Recent Development
10.22 Jinhe Biotechnology Co., Ltd.
10.22.1 Jinhe Biotechnology Co., Ltd. Company Information
10.22.2 Jinhe Biotechnology Co., Ltd. Introduction and Business Overview
10.22.3 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.22.4 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Products Offered
10.22.5 Jinhe Biotechnology Co., Ltd. Recent Development
10.23 Shanghai Shen Lian Biomedical Corporation
10.23.1 Shanghai Shen Lian Biomedical Corporation Company Information
10.23.2 Shanghai Shen Lian Biomedical Corporation Introduction and Business Overview
10.23.3 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.23.4 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Products Offered
10.23.5 Shanghai Shen Lian Biomedical Corporation Recent Development
10.24 Qingdao Vland Biotech INC.
10.24.1 Qingdao Vland Biotech INC. Company Information
10.24.2 Qingdao Vland Biotech INC. Introduction and Business Overview
10.24.3 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.24.4 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Products Offered
10.24.5 Qingdao Vland Biotech INC. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Genetically Engineered Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Genetically Engineered Vaccines Industrial Chain Analysis
11.4 Genetically Engineered Vaccines Market Dynamics
11.4.1 Genetically Engineered Vaccines Industry Trends
11.4.2 Genetically Engineered Vaccines Market Drivers
11.4.3 Genetically Engineered Vaccines Market Challenges
11.4.4 Genetically Engineered Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Genetically Engineered Vaccines Distributors
12.3 Genetically Engineered Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Genetic Recombinant Vaccine
Table 2. Major Company of Recombinant Subunit Vaccines
Table 3. Major Company of Genetic Vaccine
Table 4. Global Genetically Engineered Vaccines Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Genetically Engineered Vaccines Sales by Type (2024-2024) & (K Units)
Table 6. Global Genetically Engineered Vaccines Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Genetically Engineered Vaccines Sales by Type (2024-2024) & (US& Million)
Table 8. Global Genetically Engineered Vaccines Market Share in Value by Type (2024-2024)
Table 9. Global Genetically Engineered Vaccines Price by Type (2024-2024) & (US$/Unit)
Table 10. Global Genetically Engineered Vaccines Sales by Type (2024-2034) & (K Units)
Table 11. Global Genetically Engineered Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Genetically Engineered Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Genetically Engineered Vaccines Sales Market Share in Value by Type (2024-2034)
Table 14. Global Genetically Engineered Vaccines Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Genetically Engineered Vaccines Sales by Type (2024-2024) & (K Units)
Table 16. North America Genetically Engineered Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Genetically Engineered Vaccines Sales (K Units) by Type (2024-2024)
Table 18. Europe Genetically Engineered Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Genetically Engineered Vaccines Sales (K Units) by Type (2024-2024)
Table 20. Asia-Pacific Genetically Engineered Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Genetically Engineered Vaccines Sales (K Units) by Type (2024-2024)
Table 22. Latin America Genetically Engineered Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Genetically Engineered Vaccines Sales (K Units) by Type (2024-2024)
Table 24. Middle East and Africa Genetically Engineered Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Genetically Engineered Vaccines Sales by Company (2024-2024) & (K Units)
Table 26. Global Genetically Engineered Vaccines Sales Share by Company (2024-2024)
Table 27. Global Genetically Engineered Vaccines Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Genetically Engineered Vaccines Revenue Share by Company (2024-2024)
Table 29. Global Market Genetically Engineered Vaccines Price by Company (2024-2024) & (US$/Unit)
Table 30. Global Genetically Engineered Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Genetically Engineered Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genetically Engineered Vaccines as of 2022)
Table 33. Date of Key Manufacturers Enter into Genetically Engineered Vaccines Market
Table 34. Key Manufacturers Genetically Engineered Vaccines Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Genetically Engineered Vaccines Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Genetically Engineered Vaccines Sales by Region (2024-2024) & (K Units)
Table 38. Global Genetically Engineered Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Genetically Engineered Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Genetically Engineered Vaccines Sales Market Share in Value by Region (2024-2024)
Table 41. Global Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 42. Global Genetically Engineered Vaccines Sales by Region (2024-2034) & (K Units)
Table 43. Global Genetically Engineered Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Genetically Engineered Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Genetically Engineered Vaccines Sales Market Share in Value by Region (2024-2034)
Table 46. Global Genetically Engineered Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Genetically Engineered Vaccines Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Genetically Engineered Vaccines Sales by Application (2024-2024) & (K Units)
Table 49. Global Genetically Engineered Vaccines Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Genetically Engineered Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Genetically Engineered Vaccines Sales Market Share in Value by Application (2024-2024)
Table 52. Global Genetically Engineered Vaccines Price by Application (2024-2024) & (US$/Unit)
Table 53. Global Genetically Engineered Vaccines Sales by Application (2024-2034) & (K Units)
Table 54. Global Genetically Engineered Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Genetically Engineered Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Genetically Engineered Vaccines Sales Market Share in Value by Application (2024-2034)
Table 57. Global Genetically Engineered Vaccines Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Genetically Engineered Vaccines Sales by Application (2024-2024) (K Units)
Table 59. North America Genetically Engineered Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Genetically Engineered Vaccines Sales by Application (2024-2024) (K Units)
Table 61. Europe Genetically Engineered Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Genetically Engineered Vaccines Sales by Application (2024-2024) (K Units)
Table 63. Asia-Pacific Genetically Engineered Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Genetically Engineered Vaccines Sales by Application (2024-2024) (K Units)
Table 65. Latin America Genetically Engineered Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Genetically Engineered Vaccines Sales by Application (2024-2024) (K Units)
Table 67. Middle East and Africa Genetically Engineered Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Genetically Engineered Vaccines Sales by Country (2024-2024) & (K Units)
Table 69. North America Genetically Engineered Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Genetically Engineered Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Genetically Engineered Vaccines Sales Market Share in Value by Country (2024-2024)
Table 72. North America Genetically Engineered Vaccines Sales by Country (2024-2034) & (K Units)
Table 73. North America Genetically Engineered Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Genetically Engineered Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Genetically Engineered Vaccines Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Genetically Engineered Vaccines Sales by Country (2024-2024) & (K Units)
Table 77. Europe Genetically Engineered Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Genetically Engineered Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Genetically Engineered Vaccines Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Genetically Engineered Vaccines Sales by Country (2024-2034) & (K Units)
Table 81. Europe Genetically Engineered Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Genetically Engineered Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Genetically Engineered Vaccines Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Genetically Engineered Vaccines Sales by Region (2024-2024) & (K Units)
Table 85. Asia-Pacific Genetically Engineered Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Genetically Engineered Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Genetically Engineered Vaccines Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Genetically Engineered Vaccines Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Genetically Engineered Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Genetically Engineered Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Genetically Engineered Vaccines Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Genetically Engineered Vaccines Sales by Country (2024-2024) & (K Units)
Table 93. Latin America Genetically Engineered Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Genetically Engineered Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Genetically Engineered Vaccines Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Genetically Engineered Vaccines Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Genetically Engineered Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Genetically Engineered Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Genetically Engineered Vaccines Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Genetically Engineered Vaccines Sales by Country (2024-2024) & (K Units)
Table 101. Middle East and Africa Genetically Engineered Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Genetically Engineered Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Genetically Engineered Vaccines Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Genetically Engineered Vaccines Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Genetically Engineered Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Genetically Engineered Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Genetically Engineered Vaccines Sales Market Share in Value by Country (2024-2034)
Table 108. Pfizer Company Information
Table 109. Pfizer Introduction and Business Overview
Table 110. Pfizer Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 111. Pfizer Genetically Engineered Vaccines Product
Table 112. Pfizer Recent Development
Table 113. Merck Company Information
Table 114. Merck Introduction and Business Overview
Table 115. Merck Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 116. Merck Genetically Engineered Vaccines Product
Table 117. Merck Recent Development
Table 118. GSK Company Information
Table 119. GSK Introduction and Business Overview
Table 120. GSK Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 121. GSK Genetically Engineered Vaccines Product
Table 122. GSK Recent Development
Table 123. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Information
Table 124. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Introduction and Business Overview
Table 125. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 126. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product
Table 127. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Development
Table 128. Walvax Biotechnology Co., Ltd. Company Information
Table 129. Walvax Biotechnology Co., Ltd. Introduction and Business Overview
Table 130. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 131. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product
Table 132. Walvax Biotechnology Co., Ltd. Recent Development
Table 133. Bharat Biotech Company Information
Table 134. Bharat Biotech Introduction and Business Overview
Table 135. Bharat Biotech Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 136. Bharat Biotech Genetically Engineered Vaccines Product
Table 137. Bharat Biotech Recent Development
Table 138. Sanofi Company Information
Table 139. Sanofi Introduction and Business Overview
Table 140. Sanofi Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 141. Sanofi Genetically Engineered Vaccines Product
Table 142. Sanofi Recent Development
Table 143. Zoties Company Information
Table 144. Zoties Introduction and Business Overview
Table 145. Zoties Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 146. Zoties Genetically Engineered Vaccines Product
Table 147. Zoties Recent Development
Table 148. Elanco Company Information
Table 149. Elanco Introduction and Business Overview
Table 150. Elanco Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 151. Elanco Genetically Engineered Vaccines Product
Table 152. Elanco Recent Development
Table 153. Boehringer Ingelheim Company Information
Table 154. Boehringer Ingelheim Introduction and Business Overview
Table 155. Boehringer Ingelheim Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 156. Boehringer Ingelheim Genetically Engineered Vaccines Product
Table 157. Boehringer Ingelheim Recent Development
Table 158. Indian Immunologicals Company Information
Table 159. Indian Immunologicals Introduction and Business Overview
Table 160. Indian Immunologicals Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 161. Indian Immunologicals Genetically Engineered Vaccines Product
Table 162. Indian Immunologicals Recent Development
Table 163. China Animal Husbandry Industry Co.,Ltd. Company Information
Table 164. China Animal Husbandry Industry Co.,Ltd. Introduction and Business Overview
Table 165. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 166. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product
Table 167. China Animal Husbandry Industry Co.,Ltd. Recent Development
Table 168. Yebio Bioengineering Co., Ltd Of Qingdao Company Information
Table 169. Yebio Bioengineering Co., Ltd Of Qingdao Introduction and Business Overview
Table 170. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 171. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product
Table 172. Yebio Bioengineering Co., Ltd Of Qingdao Recent Development
Table 173. Jinyu Bio-technology Co.,ltd. Company Information
Table 174. Jinyu Bio-technology Co.,ltd. Introduction and Business Overview
Table 175. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 176. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product
Table 177. Jinyu Bio-technology Co.,ltd. Recent Development
Table 178. HVRI Company Information
Table 179. HVRI Introduction and Business Overview
Table 180. HVRI Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 181. HVRI Genetically Engineered Vaccines Product
Table 182. HVRI Recent Development
Table 183. Ringpu Biology Company Information
Table 184. Ringpu Biology Introduction and Business Overview
Table 185. Ringpu Biology Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 186. Ringpu Biology Genetically Engineered Vaccines Product
Table 187. Ringpu Biology Recent Development
Table 188. Kyoto Biken Laboratories Company Information
Table 189. Kyoto Biken Laboratories Introduction and Business Overview
Table 190. Kyoto Biken Laboratories Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 191. Kyoto Biken Laboratories Genetically Engineered Vaccines Product
Table 192. Kyoto Biken Laboratories Recent Development
Table 193. FATRO Company Information
Table 194. FATRO Introduction and Business Overview
Table 195. FATRO Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 196. FATRO Genetically Engineered Vaccines Product
Table 197. FATRO Recent Development
Table 198. Ceva Santé Animale Company Information
Table 199. Ceva Santé Animale Introduction and Business Overview
Table 200. Ceva Santé Animale Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 201. Ceva Santé Animale Genetically Engineered Vaccines Product
Table 202. Ceva Santé Animale Recent Development
Table 203. Pulike Biological Engineering,Inc. Company Information
Table 204. Pulike Biological Engineering,Inc. Introduction and Business Overview
Table 205. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 206. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product
Table 207. Pulike Biological Engineering,Inc. Recent Development
Table 208. Wuhan Hvsen Biotechnology CO.,LTD Company Information
Table 209. Wuhan Hvsen Biotechnology CO.,LTD Introduction and Business Overview
Table 210. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 211. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product
Table 212. Wuhan Hvsen Biotechnology CO.,LTD Recent Development
Table 213. Jinhe Biotechnology Co., Ltd. Company Information
Table 214. Jinhe Biotechnology Co., Ltd. Introduction and Business Overview
Table 215. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 216. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product
Table 217. Jinhe Biotechnology Co., Ltd. Recent Development
Table 218. Shanghai Shen Lian Biomedical Corporation Company Information
Table 219. Shanghai Shen Lian Biomedical Corporation Introduction and Business Overview
Table 220. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 221. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product
Table 222. Shanghai Shen Lian Biomedical Corporation Recent Development
Table 223. Qingdao Vland Biotech INC. Company Information
Table 224. Qingdao Vland Biotech INC. Introduction and Business Overview
Table 225. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 226. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product
Table 227. Qingdao Vland Biotech INC. Recent Development
Table 228. Key Raw Materials Lists
Table 229. Raw Materials Key Suppliers Lists
Table 230. Genetically Engineered Vaccines Market Trends
Table 231. Genetically Engineered Vaccines Market Drivers
Table 232. Genetically Engineered Vaccines Market Challenges
Table 233. Genetically Engineered Vaccines Market Restraints
Table 234. Genetically Engineered Vaccines Distributors List
Table 235. Genetically Engineered Vaccines Downstream Customers
Table 236. Research Programs/Design for This Report
Table 237. Key Data Information from Secondary Sources
Table 238. Key Data Information from Primary Sources
List of Figures
Figure 1. Genetically Engineered Vaccines Product Picture
Figure 2. Global Genetically Engineered Vaccines Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Genetically Engineered Vaccines Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Genetically Engineered Vaccines Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Genetic Recombinant Vaccine
Figure 6. Global Genetic Recombinant Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Recombinant Subunit Vaccines
Figure 8. Global Recombinant Subunit Vaccines Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Genetic Vaccine
Figure 10. Global Genetic Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Global Genetically Engineered Vaccines Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Genetically Engineered Vaccines Sales Market Share by Type in 2022 & 2034
Figure 13. North America Genetically Engineered Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. North America Genetically Engineered Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Europe Genetically Engineered Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Europe Genetically Engineered Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Genetically Engineered Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Genetically Engineered Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Latin America Genetically Engineered Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Genetically Engineered Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Genetically Engineered Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Genetically Engineered Vaccines Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Genetically Engineered Vaccines Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Genetically Engineered Vaccines Revenue in 2022
Figure 25. Genetically Engineered Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Veterinary Use
Figure 27. Global Veterinary Use Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Human Use
Figure 29. Global Human Use Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Genetically Engineered Vaccines Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Genetically Engineered Vaccines Sales Market Share by Application in 2022 & 2034
Figure 32. North America Genetically Engineered Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. North America Genetically Engineered Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Europe Genetically Engineered Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Europe Genetically Engineered Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Genetically Engineered Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Genetically Engineered Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Latin America Genetically Engineered Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Genetically Engineered Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Genetically Engineered Vaccines Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Genetically Engineered Vaccines Manufacturing Cost Structure
Figure 43. Genetically Engineered Vaccines Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed